Stay updated with breaking news from Clinical Microbiomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
North Carolina microbiome platform company Resilient Biotics has partnered with Maryland-based CosmosID, a microbiome analytics firm, to advance respiratory health research and therapeutic development. The goal is to explore the intricate microbiome strains that colonize the respiratory tract tissues.
Leading microbiome clinical research organisations (CROs) Clinical Microbiomics and CosmosID Inc, have partnered from across the pond to create the first-ever microbiome service company with a global infrastructure.
Targeting Microbiota 2023 will be a ground-breaking experience that will introduce you to the latest advancements in the microbiota field.
Dublin, May 09, 2023 (GLOBE NEWSWIRE) -- The "Microbiome Sequencing Services Market Size, Share & Trends Analysis Report By Technology (Sequencing By...
Global human microbiome sequencing market is estimated to exhibit a CAGR of 20.31% during the forecast period.